Disposition of 50000 shares by Sean Maduck of Corcept Therapeutics at 3.88 subject to Rule 16b-3
| CORT Stock | USD 63.37 2.14 3.50% |
Slightly above 55% of Corcept Therapeutics' private investors are presently thinking to get in. The analysis of overall sentiment of trading Corcept Therapeutics Incorporated stock suggests that some investors are interested at this time. Corcept Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Corcept Therapeutics' earnings reports, geopolitical events, and overall market trends.
Corcept |
Filed transaction by Corcept Therapeutics Incorporated Officer: See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at finance.yahoo.com
 |
Corcept Therapeutics Fundamental Analysis
We analyze Corcept Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Corcept Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Corcept Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Corcept Therapeutics is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Corcept Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Corcept Therapeutics stock to make a market-neutral strategy. Peer analysis of Corcept Therapeutics could also be used in its relative valuation, which is a method of valuing Corcept Therapeutics by comparing valuation metrics with similar companies.
Peers
Corcept Therapeutics Related Equities
| MLYS | Mineralys Therapeutics, | 10.50 | ||||
| MGTX | MeiraGTx Holdings | 2.52 | ||||
| RARE | Ultragenyx | 2.01 | ||||
| DYN | Dyne Therapeutics | 1.77 | ||||
| NXTC | NextCure | 1.33 | ||||
| INSM | Insmed | 0.77 | ||||
| CYTK | Cytokinetics | 0.45 | ||||
| EWTX | Edgewise Therapeutics | 0.28 | ||||
| KROS | Keros Therapeutics | 0.27 | ||||
| HALO | Halozyme Therapeutics | 0.12 | ||||
| IDYA | Ideaya Biosciences | 0.48 | ||||
| ERAS | Erasca | 0.71 | ||||
| GLUE | Monte Rosa | 1.03 | ||||
| ANAB | AnaptysBio | 1.11 | ||||
| NUVB | Nuvation Bio | 1.44 | ||||
| AGIO | Agios Pharm | 2.13 | ||||
| SNSE | Sensei Biotherapeutics | 2.17 |
Additional Tools for Corcept Stock Analysis
When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.